BARCLAYS PLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 90 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$151
-37.1%
51,776
-31.3%
0.00%
Q1 2024$240
-41.2%
75,345
-37.9%
0.00%
Q4 2023$408
+274.3%
121,337
+166.4%
0.00%
Q3 2023$109
+91.2%
45,542
+40.7%
0.00%
Q2 2023$57
-82.0%
32,368
-68.4%
0.00%
Q1 2023$316
+2.6%
102,545
+76.5%
0.00%
Q4 2022$308
-99.7%
58,109
+84.7%
0.00%
Q3 2022$111,000
+46.1%
31,459
+6.3%
0.00%
Q2 2022$76,000
-50.0%
29,601
-13.2%
0.00%
Q1 2022$152,00034,0990.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$11,445,0001.96%
Pentwater Capital Management LP 4,967,227$54,490,0000.66%
SECTORAL ASSET MANAGEMENT INC 838,826$9,202,0000.65%
Vivo Capital, LLC 926,447$10,163,0000.45%
Boxer Capital, LLC 1,251,055$13,724,0000.44%
Ikarian Capital, LLC 250,837$2,752,0000.12%
Perceptive Advisors 787,745$8,642,0000.09%
Rock Springs Capital Management LP 289,754$3,179,0000.07%
Regent Investment Management LLC 20,000$219,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,450,268$15,909,0000.04%
View complete list of POSEIDA THERAPEUTICS INC shareholders